RADIQAL Study (Radiation Dose and Image Quality Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 824 participants.

Also called NCT06944509

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 824 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06944509
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Czechia, Denmark, Spain (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06944509. Randomized; no masking; primary purpose other. Start 2025-05-14 (actual); primary completion 2027-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RADIQAL Study (Radiation Dose and Image Quality Trial)
Acronym
RADIQAL
Intervention (Device)
treatment with the Azurion system with Xres5
Intervention (Other)
Azurion with Clairy IQ
Lead sponsor
Philips Clinical & Medical Affairs Global (class: industry)

Record details

Record id
cardio:ct-nct06944509
Content hash
fa2993bda0ff4ec71f834001ee44789400ca0d3eccebef871f0668c39fe39bde